CryoCapCell, a company that develops and markets disruptive technologies for high-pressure vitrification, announced today a €1.5 million fund raising from the Quadrivium 1 seed capital fund managed by Seventure Partners.

Thanks to this funding, CryoCapCell will continue the development and commercial deployment of its correlative microscopy technologies using high-pressure vitrification (or “cryogenisation”), a unique process which prevents the alteration of biological structures, initially for electron-microscopy in the field of cancer research.

Xavier Heiligenstein, co-founder of CryoCapCell, explains: “In the battle against cancer, the understanding of living tissue requires dynamic, high-resolution observation on multiple scales. To help establish a precise relationship between cell morphology and function, our high-pressure vitrification technology, combined with dynamic observation tools, becomes a central element in the analysis of the biological mechanisms that underlie cancerous disorders. Our technology allows live monitoring of a biological event, thanks to a photonic microscope, followed by the vitrification of the sample in less than two seconds.”

The development of this proprietary technology has benefited from the support of the Institut Curie’s (CNRS – UMR144) and Arts et Metier’s (PIMM – CNRS UMR8006) partners, and from a solid industrial network in the Clermont-Ferrand region.

Philippe Tramoy, Investment Director at the Quadrivium 1 seed capital fund at Seventure Partners, says: “The high-pressure vitrification technology combined with optical microscopy designed by CryoCapCell is a truly disruptive innovation: it will allow scientists to better explore living samples, thus opening up completely new areas of research and application, which could have a significant impact on the study and development of biological structures.”

CryoCapCell is initially targeting research laboratories using correlative microscopy, an approach that aims to understand the relationship between a biological structure and its function. This is an indispensable process, particularly in the study of tumours.

About CryoCapCell : www.cryocapcell.com

About Seventure Partners : www.seventure.fr / Twitter @SeventureP

About the seed fund Quadrivium 1 : http://www.seventure.fr/offre-produits/nos-fonds-institutionnels/